Leukemia and Lymphoma Society

Recent papers from Leukemia and Lymphoma Society

1. BK Virus-Associated Hemorrhagic Cystitis in Nontransplanted Children With Hematological Malignancies: A Single-Center Case SeriesJournal of Pediatric Hematology/Oncology · 2026
2. Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)—a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the USLeukemia & lymphoma/Leukemia and lymphoma · 2026
3. OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AMLBlood · 2026
4. Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A‐Rearranged ALLPediatric Blood & Cancer · 2026
5. Shared decision-making, treatment priorities and communication gaps in chronic lymphocytic leukemia: an Israeli national surveyLeukemia & lymphoma/Leukemia and lymphoma · 2026
6. Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistenceHematology Transfusion and Cell Therapy · 2026
7. NOTCH1 acts as a tumor suppressor that induces early differentiation in head and neck cancerJCI Insight · 2026
8. Use of dietary and herbal supplements and communication with hematologists regarding such use among patients with CLL: a national surveyLeukemia & lymphoma/Leukemia and lymphoma · 2026
9. Actionable Steps to Address Disparities in Healthcare Among US Patients With Multiple Myeloma: A Patient PerspectiveJournal of Cancer Education · 2026
10. ITCC-101/APAL2020D: A randomized Phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamycin with or without venetoclax in children with relapsed Acute Myeloid LeukemiaBlood · 2025
11. A novel intercontinental external quality assessment program for flow cytometric measurable residual disease assessment in pediatric AMLBlood · 2025
12. Elevated clonal hematopoiesis in 9/11 first responders has distinct age-related patterns and relies on IL1RAP for clonal expansionCancer Discovery · 2025
13. Proceedings From the Second Reimagining Caregiver Workshop: Addressing Caregiver Requirements for Hematopoietic Cell TransplantBiology of Blood and Marrow Transplantation · 2025
14. Epigenomic diagnosis and prognosis of Acute Myeloid LeukemiaNature Communications · 2025
15. A charter for improving care for people living with chronic lymphocytic leukemia: six principles for excellenceLeukemia & lymphoma/Leukemia and lymphoma · 2025
16. A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 YearsCancer Research Communications · 2025
17. Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid LeukemiaJAMA Network Open · 2025
18. Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1 -Mutated or KMT2A -Rearranged AMLJournal of Clinical Oncology · 2025
19. Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD)BMJ Open · 2025
20. Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: a retrospective studyFrontiers in Immunology · 2025